NVAX stock price sits at $4.66 amid heightened chatter about mergers in the biotech sector. A wave of consolidation could re-rate valuations, benefiting companies with unique IP portfolios like NVAX. 15 hours ago · Bad Bunny makes an immediate return to Saturday Night Live to kick off Season 51 A whole mess of cast changes can't change the curriculum for SNL 51 It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. NVAX stock price recorded a 0.9% gain to $4.64 despite broader healthcare sector weakness. Technical setups suggest NVAX is consolidating ahead of a possible breakout, contingent on biotech market sentiment turning bullish.